Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris.
The bivalent anti-human anti-T cell immunotoxin A-dmDT390-bisFv(G(4)S) was developed for treatment of T cell leukemia, autoimmune diseases, and tolerance induction for transplantation. The multi-domain structure of the bivalent immunotoxin hinders efficient production in Escherichia coli and most eukaryotes are sensitive to the toxin. However, Pichia pastoris has a tolerance to levels of DT (diphtheria toxin) that were previously observed to intoxicate wild type eukaryotic cells, including Saccharomyces cerevisiae. This tolerance has permitted the optimization of the secreted expression of A-dmDT390-bisFv(G(4)S) in P. pastoris under the control of AOX1 (alcohol oxidase 1) promoter. The original DNA sequence of A-dmDT390-bisFv(G(4)S) was not expressed in P. pastoris because of several AT-rich regions, which induce an early termination of transcription. After DNA rebuilding for abolishing AT-rich regions and codon optimization, the immunotoxin could be expressed up to 10mg/L in the shake flask culture. No differences in the expression levels of immunotoxin were observed by using different secretional signal sequences, Mut(s) (methanol utilization slow phenotype) or Mut(+) (methanol utilization plus phenotype) phenotypes. Buffered complex medium (pH 7.0) having 1% casamino acids provided the highest expression in shake flask culture and PMSF (phenylmethylsulfonyl fluoride) in the range of 1 to 3mM further improved the expression level presumably by inhibiting protein degradation. The immunotoxin was purified by DEAE (diethylaminoethyl) Sepharose ion exchange chromatography and Protein L affinity chromatography. The immunotoxin purified from P. pastoris culture was as fully functional as that expressed in a toxin resistant mutant CHO (Chinese hamster ovary) cell line. Our results demonstrate that P. pastoris is an ideal system for expression of toxin-based fusion proteins.
Section on Biophysical Chemistry, Laboratory of Molecular Biology, National Institute of Mental Health, National Institutes of Health, 36 RM 1B08, 36 Convent Drive, Bethesda, MD 20892-4034, USA.
Jung Hee
JH
Woo
Yuan Yi
YY
Liu
Askale
A
Mathias
Scott
S
Stavrou
Zhirui
Z
Wang
Jerry
J
Thompson
David M
DM
Neville
D000818:Animals; D000937:Antigen-Antibody Reactions / Q000276:immunology*; D001482:Base Composition; D003062:Codon / Q000235:genetics; D003470:Culture Media; D018628:Gene Dosage; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D007128:Immunoglobulin Fragments / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D000922:Immunotoxins / Q000737:chemistry / Q000235:genetics* / Q000302:isolation & purification* / Q000633:toxicity; D019169:Jurkat Cells; D008969:Molecular Sequence Data; D010843:Pichia / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000633:toxicity; D013601:T-Lymphocytes / Q000276:immunology*
D003062:Codon; D003470:Culture Media; D007128:Immunoglobulin Fragments; D000922:Immunotoxins; D011993:Recombinant Fusion Proteins